Advanced musculoskeletal MRI at ultra-high field (7 T)

Imaging in Medicine

Volumn 2, Issue 1, 2010, Pages 99-114

  Trattnig, Siegfried ^a   Friedrich, Klaus M ^a   Bogner, Wolfgang ^a   Welsch, Goetz H ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

7 Tesla; 31phosphorus spectroscopy; articular cartilage; multiparametric imaging; sodium imaging; ultra high field; ultra high resolution

Indexed keywords

COLLAGEN FIBER; COLLAGEN TYPE 2; GADOLINIUM; PENTETIC ACID; PHOSPHORUS 31; PROTEOGLYCAN; SODIUM;

ANKLE; ANTERIOR CRUCIATE LIGAMENT; ARTICULAR CARTILAGE; BIOMECHANICS; ENERGY METABOLISM; HIP; HUMAN; IMAGE QUALITY; KNEE; MUSCULOSKELETAL SYSTEM EXAMINATION; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEUS PULPOSUS; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SHOULDER; SIGNAL NOISE RATIO; TISSUE REPAIR; ULTRASTRUCTURE; WRIST;

EID: 77954114754     PISSN: 17555191     EISSN: 17555205     Source Type: Journal    
DOI: 10.2217/iim.09.26     Document Type: Review

References (106)

1. Krug R, Banerjee S, Han ET, Newitt DC, Link TM, Majumdar S: Feasibility of in vivo structural ana lysis of high-resolution magnetic resonance images of the proximal femur. Osteoporos. Int. 16(11), 1307-1314 (2005).
2. Mamisch TC, Werlen S, Zilkens C et al.: Radiological diagnosis of femoroacetabular impingement. Radiologe 49(5), 425-433 (2009).
3. Sundberg TP, Toomayan GA, Major NM: Evaluation of the acetabular labrum at 3.0-T MR imaging compared with 1.5-T MR arthrography: preliminary experience. Radiology 238(2), 706-711 (2006).
4. Mamisch TC, Bittersohl B, Hughes T et al.: Magnetic resonance imaging of the hip at 3 Tesla: clinical value in femoroacetabular impingement of the hip and current concepts. Semin. Musculoskelet. Radiol. 12(3), 212-222 (2008).
5. Eckstein F, Charles HC, Buck RJ et al.: Accuracy and precision of quantitative assessment of cartilage morphology by magnetic resonance imaging at 3.0T. Arthritis Rheum. 52(10), 3132-3136 (2005). (Pubitemid 41447094)
6. Chang G, Regatte RR, Schweitzer ME: Olympic fencers: adaptations in cortical and trabecular bone determined by quantitative computed tomography. Osteoporos. Int. 20(5), 779-785 (2009).
7. Goldstein SA, Goulet RW, Mccubbrey D: Measurement and signifcance of 3-dimensional architecture to the mechanical integrity of trabecular bone. Calcif. Tissue Int. 53, S127-S133 (1993).
8. Kleerekoper M, Villanueva AR, Stanciu J, Rao DS, Parftt AM: The role of 3-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif. Tissue Int. 37(6), 594-597 (1985).
9. Borah B, Dufresne TE, Chmielewski PA, Gross GJ, Prenger MC, Phipps RJ: Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. J. Bone Miner. Res. 17(7), 1139-1147 (2002).
10. Ding M, Odgaard A, Linde F, Hvid I: Age-related variations in the microstructure of human tibial cancellous bone. J. Orthop. Res. 20(3), 615-621 (2002).
11. Krug R, Carballido-Gamio J, Banerjee S, Burghardt AJ, Link TM, Majumdar S: In vivo ultra-high-feld magnetic resonance imaging of trabecular bone microarchitecture at 7 T. J. Magn. Reson. Imaging 27(4), 854-859 (2008).
12. Stahl R, Krug R, Kelley DAC et al.: Assessment of cartilage-dedicated sequences at ultra-high-feld MRI: comparison of imaging performance and diagnostic confdence between 3.0 and 7.0 T with respect to osteoarthritis- induced changes at the knee joint. Skeletal Radiol. 38(8), 771-783 (2009).
13. Kraff O, Theysohn JM, Maderwald S et al.: MRI of the knee at 7.0 Tesla. Rofo: Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren 179(12), 1231-1235 (2007).
14. Bauer JS, Monetti R, Krug R et al.: Advances of 3T MR imaging in visualizing trabecular bone structure of the calcaneus are partially SNR-independent: ana lysis using simulated noise in relation to micro-CT, 1.5T MRI, and biomechanical strength. J. Magn. Reson. Imaging 29(1), 132-140 (2009).
15. Bauer JS, Banerjee S, Henning TD, Krug R, Majumdar S, Link TM: Fast high-spatial-resolution MRI of the ankle with parallel imaging using GRAPPA at 3 T Am. J. Roentgenol. 189(1), 240-245 (2007).
16. Barr C, Bauer JS, Malfair D et al.: MR imaging of the ankle at 3 Tesla and 1.5 Tesla: protocol optimization and application to cartilage, ligament and tendon pathology in cadaver specimens. Eur. Radiol. 17(6), 1518-1528 (2007).
17. Banerjee S, Choudhury S, Han ET et al.: Autocalibrating parallel imaging of in vivo trabecular bone micro architecture at 3 Tesla. Magn. Reson. Med. 56(5), 1075-1084 (2006).
18. Banerjee S, Krug R, Carballido-Gamio J et al.: Rapid in vivo musculoskeletal MR with parallel imaging at 7T Magn. Reson. Med. 59(3), 655-660 (2008).
19. Jung JY, Yoon YC, Yi SK, Yoo J, Choe BK: Comparison study of indirect MR arthrography and direct MR arthrography of the shoulder. Skeletal Radiol. 38(7), 659-667 (2009).
20. Magee T: 3T MR imaging of the shoulder: is MR arthrography necessary Am. J. Roentgenol. 192(5), 86-92 (2009).
21. Anderson ML, Skinner JA, Felmlee JP, Berger RA, Amrami KK: Diagnostic comparison of 1.5 Tesla and 3.0 Tesla preoperative MRI of the wrist in patients with ulnar-sided wrist pain. J. Hand Surg. Am. 33A(7), 1153-1159 (2008).
22. Farooki S, Ashman CJ, Yu JS, Abduljalil A, Chakeres D: In vivo high-resolution MR imaging of the carpal tunnel at 8.0 Tesla. Skeletal Radiol. 31(8), 445-450 (2002).
23. Behr B, Stadler J, Michaely HJ, Damert HG, Schneider W: MR imaging of the human hand and wrist at 7 T Skeletal Radiol. 38(9), 911-917 (2009).
24. Friedrich KM, Chang G, Vieira RLR et al.: In vivo 7.0-Tesla magnetic resonance imaging of the wrist and hand: technical aspects and applications. Semin. Musculoskelet. Radiol. 13(1), 74-84 (2009).
25. Mankin HJ: Biochemical and metabolic aspects of osteoarthritis. Orthop. Clin. North Am. 2(1), 19-31 (1971).
26. Roughley PJ, Lee ER: Cartilage proteoglycans: structure and potential functions. Microsc. Res. Tech. 28(5), 385-397 (1994).
27. Lohmander LS: Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease. J. Anat. 184(Pt 3), 477-492 (1994).
28. Grushko G, Schneiderman R, Maroudas A: Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of ageing and degeneration in human hip cartilage. Connect. Tissue Res. 19(2-4), 149-176 (1989).
29. Maroudas A, Muir H, Wingham J: The correlation of fxed negative charge with glycosaminoglycan content of human articular cartilage. Biochim. Biophys. Acta 177(3), 492-500 (1969).
30. Lesperance LM, Gray ML, Burstein D: Determination of fxed charge density in cartilage using nuclear magnetic resonance. J. Orthop. Res. 10(1), 1-13 (1992).
31. Borthakur A, Shapiro EM, Beers J, Kudchodkar S, Kneeland JB, Reddy R: Sensitivity of MRI to proteoglycan depletion in cartilage: comparison of sodium and proton MRI. Osteoarthr. Cartil. 8(4), 288-293 (2000).
32. Shapiro EM, Borthakur A, Gougoutas A, Reddy R: 23Na MRI accurately measures fxed charge density in articular cartilage. Magn. Reson. Med. 47(2), 284-291 (2002).
33. Borthakur A, Shapiro EM, Akella SV, Gougoutas A, Kneeland JB, Reddy R: Quantifying sodium in the human wrist in vivo by using MR imaging. Radiology 224(2), 598-602 (2002).
34. 23Na MRI and MRS. J. Magn. Reson. 142(1), 24-31 (2000).
35. Wheaton AJ, Borthakur A, Dodge GR, Kneeland JB, Schumacher HR, Reddy R: Sodium magnetic resonance imaging of proteoglycan depletion in an in vivo model of osteoarthritis. Acad. Radiol. 11(1), 21-28 (2004).
36. Burstein D, Velyvis J, Scott KT et al.: Protocol issues for delayed Gd(DTPA) (2-)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn. Reson. Med. 45(1), 36-41 (2001).
37. Hoult DI, Chen CN, Sank VJ: The feld dependence of NMR imaging. II. Arguments concerning an optimal feld strength. Magn. Reson. Med. 3(5), 730-746 (1986).
38. Chen CN, Sank VJ, Cohen SM, Hoult DI: The feld dependence of NMR imaging. I. Laboratory assessment of signal-to-noise ratio and power deposition. Magn. Reson. Med. 3(5), 722-729 (1986).
39. Ugurbil K, Adriany G, Andersen P et al.: Ultrahigh feld magnetic resonance imaging and spectroscopy. Magn. Reson. Imaging 21(10), 1263-1281 (2003). (Pubitemid 38202250)
40. Reddy R, Insko EK, Noyszewski EA, Dandora R, Kneeland JB, Leigh JS: Sodium MRI of human articular cartilage in vivo. Magn. Reson. Med. 39(5), 697-701 (1998).
41. Borthakur A, Mellon E, Niyogi S, Witschey W, Kneeland JB, Reddy R: Sodium and T1rho MRI for molecular and diagnostic imaging of articular cartilage. NMR Biomed. 19(7), 781-821 (2006).
42. McKenzie CA, Williams A, Prasad PV, Burstein D: Three-dimensional delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at 1.5T and 3.0T. J. Magn. Reson. Imaging 24(4), 928-933 (2006).
43. Burstein D, Velyvis J, Scott KT et al.: Protocol issues for delayed Gd(DTPA) (2-)-enhanced MRI: (dGEMRIC) for clinical evaluation of articular cartilage. Magn. Reson. Med. 45(1), 36-41 (2001).
44. Kim YJ, Jaramillo D, Millis MB, Gray ML, Burstein D: Assessment of early osteoarthritis in hip dysplasia with delayed gadolinium-enhanced magnetic resonance imaging of cartilage. J. Bone Joint Surg. Am. 85A(10), 1987-1992 (2003).
45. Tiderius CJ, Olsson LE, Leander P, Ekberg O, Dahlberg L: Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis. Magn. Reson. Med. 49(3), 488-492 (2003).
46. Burstein D, Gray ML: Is MRI fulflling its promise for molecular imaging of cartilage in arthritis Osteoarthr. Cartil. 14(11), 1087-1090 (2006).
47. Watanabe A, Wada Y, Obata T et al.: Delayed gadolinium-enhanced MR to determine glycosaminoglycan concentration in reparative cartilage after autologous chondrocyte implantation: preliminary results. Radiology 239(1), 201-208 (2006).
48. Williams A, Mikulis B, Krishnan N, Gray M, McKenzie C, Burstein D: Suitability of T(1Gd) as the dGEMRIC index at 1.5T and 3.0T. Magn. Reson. Med. 58(4), 830-834 (2007).
49. Regatte RR, Schweitzer ME: Ultra-high-feld MRI of the musculoskeletal system at 7.0T. J. Magn. Reson. Imaging 25(2), 262-269 (2007).
50. 2 N-acetylaspartate, and creatine in human brain using Hahn and Carr-Purcell spin echoes at 4 T and 7 T. Magn. Reson. Med. 47(4), 629-633 (2002).
51. Christoforidis GA, Grecula JC, Newton HB et al.: Visualization of microvascularity in glioblastoma multiforme with 8-T high-spatial-resolution MR imaging. AJNR Am. J. Neuroradiol. 23(9), 1553-1556 (2002).
52. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ: Comparison of magnetic properties of MRI contrast media solutions at different magnetic feld strengths. Invest. Radiol. 40(11), 715-724 (2005).
53. Trattnig S, Marlovits S, Gebetsroither S et al.: Three-dimensional delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) for in vivo evaluation of reparative cartilage after matrix-associated autologous chondrocyte transplantation at 3.0T: preliminary results. J. Magn. Reson. Imaging 26(4), 974-982 (2007).
54. Rinck PA, Fischer HW, Vander Elst L, Van Haverbeke Y, Muller RN: Field-cycling relaxometry: medical applications. Radiology 168(3), 843-849 (1988).
55. Wood ML, Hardy PA: Proton relaxation enhancement. J. Magn. Reson. Imaging 3(1), 149-156 (1993).
56. Robitaille PM: On RF power and dielectric resonances in UHF MRI. NMR Biomed. 12(5), 318-319 (1999).
57. Hoult DI, Phil D: Sensitivity and power deposition in a high-feld imaging experiment. J. Magn. Reson. Imaging 12(1), 46-67 (2000).
58. Kangarlu A, Baertlein BA, Lee R et al.: Dielectric resonance phenomena in ultra high feld MRI. J. Comput. Assist. Tomogr. 23(6), 821-831 (1999).
59. Buckwalter JA, Mankin HJ: Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr. Course Lect. 47 487-504, 562 (1998).
60. Poole AR, Kojima T, Yasuda T, Mwale F, Kobayashi M, Laverty S: Composition and structure of articular cartilage-a template for tissue repair. Clin. Orthop. Relat. Res. (391), S26-S33 (2001).
61. Goodwin DW, Zhu HQ, Dunn JF: In vitro MR imaging of hyaline cartilage: correlation with scanning electron microscopy. Am. J. Roentgenol. 174(2), 405-409 (2000).
62. Mosher TJ, Dardzinski BJ: Cartilage MRI T2 relaxation time mapping: overview and applications. Semin. Musculoskelet. Radiol. 8(4), 355-368 (2004).
63. 2 2 articular cartilage. Invest. Radiol. 43(9), 619-626 (2008).
64. Messner K, Gao J: The menisci of the knee joint. Anatomical and functional characteristics, and a rationale for clinical treatment. J. Anat. 193 (Pt 2) 161-178 (1998).
65. Goodwin DW, Wadghiri YZ, Dunn JF: Micro-imaging of articular cartilage: T2, proton density, and the magic angle effect. Acad. Radiol. 5(11), 790-798 (1998).
66. Smith HE, Mosher TJ, Dardzinski BJ et al.: Spatial variation in cartilage T of the knee. J. Magn. Reson. Imaging 14(1), 50-55 (2001).
67. Watrin-Pinzano A, Ruaud JP, Cheli Y et al.: Evaluation of cartilage repair tissue after biomaterial implantation in rat patella by using T mapping. MAGMA 17(3-6), 219-228 (2004).
68. White LM, Sussman MS, Hurtig M, Probyn L, Tomlinson G, Kandel R: Cartilage T assessment: differentiation of normal hyaline cartilage and reparative tissue after arthroscopic cartilage repair in equine subjects. Radiology 241(2), 407-414 (2006).
69. David-Vaudey E, Ghosh S, Ries M, Majumdar S: T relaxation time measurements in osteoarthritis. Magn. Reson. Imaging 22(5), 673-682 (2004).
70. Mosher TJ, Smith HE, Collins C et al.: Change in knee cartilage T at MR imaging after running: a feasibility study. Radiology 234(1), 245-249 (2005).
71. Trattnig S, Mamisch TC, Welsch GH et al.: Quantitative T-2 mapping of matrix-associated autologous chondrocyte transplantcation at 3 Tesla-an in vivo cross-sectional study. Invest. Radiol. 42(6), 442-448 (2007).
72. Gold GE, Han E, Stainsby J, Wright G, Brittain J, Beaulieu C: Musculoskeletal MRI at 3.0 T: relaxation times and image contrast. AJR Am. J. Roentgenol. 183(2), 343-351 (2004).
73. Stanisz GJ, Odrobina EE, Pun J et al.: T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn. Reson. Med. 54(3), 507-512 (2005).
74. Bolog N, Nanz D, Weishaupt D: Muskuloskeletal MR imaging at 3.0 T: current status and future perspectives. Eur. Radiol. 16(6), 1298-1307 (2006).
75. Pakin SK, Cavalcanti C, La Rocca R, Schweitzer ME, Regatte RR: Ultra-high-feld MRI of knee joint at 7.0T: preliminary experience. Acad. Radiol. 13(9), 1135-1142 (2006).
76. Mosher TJ, Collins CM, Smith HE et al.: Effect of gender on in vivo cartilage magnetic resonance imaging T2 mapping. J. Magn. Reson. Imaging 19(3), 323-328 (2004).
77. 2 after matrix-associated autologous chondrocyte transplantation (MACT): full-thickness and zonal evaluation to visualize the maturation of cartilage repair tissue. J. Orthop. Res. 27(7), 957-963 (2009).
78. 2 1253-1262 (2009).
79. Welsch GH, Mamisch TC, Domayer SE et al.: Cartilage T2 assessment at 3-T MR imaging: in vivo differentiation of normal hyaline cartilage from reparative tissue after two cartilage repair procedures-initial experience. Radiology 247(1), 154-161 (2008).
80. 2 MR imaging: comparison with severity of knee osteoarthritis. Radiology 232(2), 592-598 (2004).
81. Murphy BJ: Evaluation of grades 3 and 4 chondromalacia of the knee using T*-weighted 3D gradient-echo articular cartilage imaging. Skeletal Radiol. 30(6), 305-311 (2001).
82. 2-star relaxation as a means to differentiate cartilage repair tissue after microfracturing therapy. Intern. Soc. Magn. Reson. Med. 15, 183 (2007).
83. 2* mapping of the human femoral. tibial cartilage at 1.5 and 3 Tesla. Intern. Soc. Magn. Reson. Med. 15, 516 (2007).
84. Boesch C: Musculoskeletal spectroscopy. J. Magn. Reson. Imaging 25(2), 321-338 (2007).
85. Kemp GJ, Meyerspeer M, Moser E: Absolute quantifcation of phosphorus metabolite concentrations in human muscle in vivo by P-31 MRS: a quantitative review. NMR Biomed. 20(6), 555-565 (2007).
86. Phielix E, Mensink M: Type 2 diabetes mellitus and skeletal muscle metabolic function. Physiol. Behav. 94(2), 252-258 (2008).
87. Prompers JJ, Jeneson JAL, Drost MR, Oomens CCW, Strijkers GJ, Nicolay K: Dynamic MRS and MRI of skeletal muscle function and biomechanics. NMR Biomed. 19(7), 927-953 (2006).
88. 31P MR spectroscopic assessment of muscle in patients with myasthenia gravis before and after thymectomy: initial experience. Radiology 247(1), 162-169 (2008).
89. Lodi R, Hart PE, Rajagopalan B et al.: Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann. Neurol. 49(5), 590-596 (2001).
90. Szendroedi J, Schmid AI, Chmelik M et al.: Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in Type 2 diabetes. PLoS Med. 4(5), 858-867 (2007).
91. Szendroedi J, Schmid AI, Meyerspeer M et al.: Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. Diabetes Care 32(4), 677-679 (2009).
92. Taylor DJ: Clinical utility of muscle MR spectroscopy. Semin. Musculoskelet. Radiol. 4(4), 481-502 (2000).
93. Krssak M, Mlynarik V, Meyerspeer M, Moser E, Roden M: H-1 NMR relaxation times of skeletal muscle metabolites at 3 T. MAGMA 16(4), 155-159 (2004).
94. Bogner W, Chmelik M, Schmid AI, Moser E, Trattnig S, Gruber S: Assessment of P-31 relaxation times in the human calf muscle: a comparison between 3 T and 7 T In vivo. Magn. Reson. Med. 62(3), 574-582 (2009).
95. Argov Z, DeStefano N, Arnold DL: ADP recovery after a brief ischemic exercise in normal and diseased human muscle-A P-31 MRS study. NMR Biomed. 9(4), 165-172 (1996).
96. Taylor DJ, Kemp GJ, Radda GK: Bioenergetics of skeletal-muscle in mitochondrial myopathy. J. Neurol. Sci. 127(2), 198-206 (1994).
97. Kuhl CK, Layer G, Traber F, Zierz S, Block W, Reiser M: Mitochondrial encephalomyopathy-correlation of P-31 exercise MR spectroscopy with clinical fndings. Radiology 192(1), 223-230 (1994).
98. Matthews PM, Allaire C, Shoubridge EA, Karpati G, Carpenter S, Arnold DL: In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology 41(1), 114-120 (1991).
99. Duboc D, Jehenson P, Dinh ST, Marsac C, Syrota A, Fardeau M: Phosphorus NMR-spectroscopy study of muscular enzyme defciencies involving glycogenolysis and glycolysis. Neurology 37(4), 663-671 (1987).
100. Lodi R, Cooper JM, Bradley JL et al.: Defcit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc. Natl Acad. Sci. USA 96(20), 11492-11495 (1999).
101. Taivassalo T, Matthews PM, DeStefano N et al.: Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase defciency. Neurology 47(2), 529-534 (1996).
102. Cottin Y, Verges B, Walker PM, Brunotte F, Wolf JE, Casillas JM: Muscle metabolism assessed by phosphorus-31 nuclear magnetic resonance spectroscopy after myocardial infarction in rehabilitated patients: a 1-year follow-up. PLoS Med. 20(1), 44-49 (2000).
103. Negendank W: Studies of human tumors by MRS-a review. NMR Biomed. 5(5), 303-324 (1992).
104. 31P MRS of experimental tumours. NMR Biomed. 6(6), 345-365 (1993).
105. Pedersen BL, Baekgaard N, Quistorff B: Muscle mitochondrial function in patients with Type 2 diabetes mellitus and peripheral arterial disease: implications in vascular surgery. Eur. J. Vasc. Endovasc. Surg. 38(3), 356-364 (2009).
106. 31P MR spectroscopy and in vitro markers of oxidative capacity in Type 2 diabetes patients. MAGMA 19(6), 321-331 (2006).